(Date:11/25/2009)...--SinovacBiotechLtd.(SVA),aleadingdeveloperandpro...tventure(JV)agreementtoestablishSinovac(Dalian)Vac...search,develop,produce,andcommercializehuman-useva...enceindevelopingandcommercializingworld-classvacci...cturingfacilitiesand,establishedoperatinginfrastru...
(Date:11/24/2009)... . , Whether it,s CD packaging, containers o... Identification) are increasingly finding their wa...el objects or goods and identify them automaticall...read and process the data contained in the label. ...ion conditions of up to 100 degrees Celsius. But a...
(Date:11/24/2009)...investment bank KTA Capital,s client Neuren Pharma...onvertible note private placement with a U.S. inst...nged by KTA Capital as Neuren,s exclusive placemen...w York (PRWEB) November 23, 2009 -- The independen...;KTA Capital") has announced that its client ...
(Date:11/24/2009)...Newswire-FirstCall/--deCODE,genetics,Inc.(Nasdaq: ...eNasdaqStockMarketthattradinginthecompany,scommons...NSEwillbefiledwiththe,SecuritiesandExchangeCommiss...onNasdaq,unlessthecompanyfilesanappealtotheNasdaq,...nappeal,which,willstaythesuspensionanddelistingthr...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Intelligence inside metal components 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3